Clinical immunological and therapeutic aspects of autoimmune encephalitis

Recent Patents on CNS Drug Discovery

Volumn 3, Issue 1, 2008, Pages 16-22

  Vitaliani, Roberta ^a,b   Zoccarato, Mauro ^a   Vianello, Marika ^b   Giometto, Bruno ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Treviso General Hospital   (Italy)

Author keywords

Anti neuronal antibodies; Autoimmunity; Encephalitis; Immunotherapy; Neuroimmunology; Neurooncology

Indexed keywords

ABATACEPT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; EPRATUZUMAB; GLUTAMATE DECARBOXYLASE ANTIBODY; HU ANTIBODY; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROLEPTIC AGENT; PROTEIN A; RITUXIMAB; STEROID; THYROID ANTIBODY;

ALLERGIC ENCEPHALITIS; ANTIBODY BLOOD LEVEL; AUTOIMMUNE POLYENDOCRINOPATHY; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EARLY INTERVENTION; HASHIMOTO ENCEPHALOPATHY; HEMISPHERECTOMY; HUMAN; HYPOTHESIS; IMMUNOADSORPTION; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; LUNG SMALL CELL CANCER; MUSCLE RIGIDITY; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RASMUSSEN SYNDROME; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY RESISTANCE; TREATMENT OUTCOME;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BRAIN DISEASES; HUMANS;

EID: 38949197362     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488908783421465     Document Type: Review

References (60)

1. Posner JB. In: Posner JB Ed, Neurologic complications of cancer. Paraneoplastic syndromes. Philadelphia, FA Davis Co. 1995:353-85.
2. Henson RA, Hoffman HL, Urich H. Encephalomyelitis with carcinoma. Brain 1965; 88:449-464.
3. Henson RA, Urich H. In Henson RA and Urich H (Eds), Cancer and the nervous system. Encephalomyelitis with carcinoma: Oxford, Blackwell. 1982; 314-345.
4. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Anti neuronal antibody that also reacts with the tumor. Am J Med 1986; 80: 45-52.
5. Luchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncological profiles of patients sieropositive for type 1 anti-neuronal nuclear auto-antibodies. Neurology 1998; 50:652-657.
6. Dalmau J, Graus J, Rosenblum MK, Posner J. Anti-Hu associated paraneoplastic encephalomyelitias/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71:59-72.
7. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psichiatry 1948; 11:73-87.
8. Antoine J, Honnorat J, Koeing F, Aguera M, Berlin MF, Michel D. Posterior uveitis and paraneoplastic encephalomyelitis with auto-antibodies reacting against cytoplasmic protein of brain and retina. J Neurol Sci 1993; 163: 159-162.
9. Honnorat J, Byk T, Kuster I, et al. Ulip/CRMP5 proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur J Neurosci 1999; 11: 4226-4232.
10. Ricard D, Rogemond V, Charrier E, et al. Isolation and expression. pattern of human Unc-33-like phosphoprotein6/collapsin response mediator protein 5(Ulip6/CRMP5). coexistence with Ulip2/CRMP2 in Sema3A-sensitive oligodendrocytes. J Neurosci. 2001; 21:7203-7214.
11. Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002; 51:625-630.
12. Rogemond V, Honnorat J. Anti-CV2 antibodies and paraneoplastic neurological syndromes. Clin Rev Allergy Immunol 2000; 19(1):51-59.
13. Folli F, Solimena M, Cofiell R, et al. Autoantibodies; to a 128-kd protem in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993; 328:564-551.
14. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vescicle-associated protein amphiphysin is the 128 kD autoantigen of the Stiff-Man syndrome with breast cancer. J Exp Med 1993; 178:2219-2223.
15. Dropcho EJ. Antiamphiphysin antibodies with small cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol 1996; 39:659-667.
16. Saiz A, Dalmau J, Butler MH, et al. Antiamphiphysin autoantibodies in patients with pataneoplastic neurological disorders associated with small cell lung cancer. J Neurol Neurosurg Psichiatry 1999; 66:214-217.
17. Brierley JB, Corselly JAN, Hierons R, Nevin S. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960; 83: 357-369.
18. Corsellis JAN, Goldberg GJ, Norton AR. 'Limbic encephalitis' and its association with carcinoma. Brain 1968; 91: 481-196.
19. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-1494.
20. Almowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 1997;120:923-928.
21. Dalmau J, Gultekin SH, Voltz R, et al. A novel neuron-testis specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999; 122:27-39.
22. Dalmau J, Graus F, Villarejo A, et al. Meneses Pand Rosenfeld MR. Clinical analysis of anti-Ma2 associated encephalitis. Brain 2004; 127(8): 1831-1844.
23. Vitaliani R, Mason B, Ances B, Zwerdling T, Jang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms and hypoventilation in ovarian teratoma. Ann Neurol, 2005 Sep 21; 58(4): 594-604.
24. Dalmau J, Tuzun E, Wu MY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007 Jan;61(1):25-36.
25. Hart IK. Acquired neuromyatonia: a new autoantibody-mediated neuronal potassium channelopathy. Am J Med Sci 2000; 319:209-216.
26. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124:2417-2426.
27. Loscher WN, Wanschitz J, Reiners K, Quasthoff S. Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve 2004; 30: 157-163.
28. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain 2004; 127:701-712.
29. Whitely AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Its relation to "subacute myoclonic spinal neuronitis" and to the "stiff-man syndrome". Brain 1976; 99:27-42.
30. Menick HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 2002; 17(5):853-886.
31. Rasmussen T, Olszeweski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958; 8:435-445.
32. Dulac O. Rasmussen's syndrome. Current Opin Neuol 1996; 9:75-77.
33. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996; 46:242-246.
34. Antozzi C, Granata T, Aurisano N, et al. Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 1998; 51:302-305.
35. Rogers SW, Andrews Pi, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265:648-651.
36. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966; 2: 512-514.
37. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment J Neurol 1996; 243: 585-593.
38. Ferracci F, Moretto G, Candeago RM, et al. Antithyroid antibodies in CSF. Their role in the pathogenesis of Hashimoto encephalopathy. Neurology 2003; 60: 712-714.
39. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth?. Arch Neurol 2003; 60:164-170.
40. Ochi H, Horiuchi I, Araki N, et al. Proteomic analysis of human brain identifies α-enolase as a novel autoantigen in Hashimoto's encephalopathy. FEBS Letters 2002; 528 (1-3):197-202.
41. Oide T, Tokuda T, Yazaki K et al. Anti-neuronal antibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical and biochemical analysis of two patients. J Neurol Sci 2004; 217: 7-12.
42. Moore PM, Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry 1998; 65: 10-22.
43. Stubgen JP. Nervous system lupus mimics limbic encephalitis. Lupus 1998; 7:557-560.
44. William RC, Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis-Rheum 2004; 50(4): 1239-1247.
45. Sanna G, Piga M, Terryberry JW, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9:573-583.
46. Reichlin M. Ribosomal P antibodies and CNS Lupus. Lupus (2003);12: 916-918.
47. Denburg SD, Denburg JA. In: Lahita R, Ed, Systemic lupus erythematosus. Cognitive dysfunctions in SLE. Toronto, Academic Press. 1999; 611-629.
48. DeGiorgio LA, Kostanitinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A substet of lupus dsDNA antibodies cross react with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7:1189-1193.
49. Giometto B, Nicolao P, Macucci P, Tavolato B, Foxon R, Bottazzo GF. Temporal lobe epilepsy associated with glutammic acid-decarboxyilase antibodies. Lancet 1998; 352: 457.
50. Marchiori GC, Vaglia A, Vianello M, Bardin PG, Giometto B. Encephalitis associated with glutammic acid decarboxylase autoantibodies. Neurology 2001; 56: 814.
51. Madrid A, Gil-Peralta A, Gil Neciga E, Gonzales J, Jarrin. S. Morvan's fibrillary chorea. remission after plasmapheresis. J Neurol 1996; 243: 350-353.
52. Kleim-Gluibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide and methylprednisone. J Neurol Neurosurg Psychiatry 2000; 68: 479-482.
53. Graus F, Kleime-Guibert F, René R, et al. Anti-Hu associated encepphalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-1148.
54. Bataller L, Dalmau J. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment. Semin Neurol. 2003 Jun; 23(2): 215-24.
55. Castillo P, Woodruff B, Caselli R, et al. Steroid responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006; 63: 197-202.
56. Hussian NS, Rumbaug J, Kerr D, Nath A, Hills AE. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005; 64: 165-166.
57. D'Cruz David P. Systemic lupus erytematosus. BMJ 2006; 332:890-894.
58. Hanly JK Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005; 19(5): 799-821.
59. Stojanovich L, Zandman Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestation in systemic lupus erytematosus. Autoimmun Rev 2007; 6(6): 421-426.
60. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007; 13: 261-271.